Considerations for long-term use of erdafitinib

Erdafitinib, an oral targeted drug, is often used to treat adult patients with advanced or metastatic urothelial cancer (UC). So, do patients need to take this type of drug for a long time? This mainly depends on several key factors.

We need to look at the patient's disease progression and treatment response. The main goal of erdafitinib is to control tumor growth and metastasis, thereby prolonging survival and improving patients' quality of life. If the patient's condition stabilizes or shows significant improvement after taking it, continued use may be beneficial.

The efficacy and safety of erdafitinib are also issues we must consider. Although this drug works well for some patients, everyone's physical condition and drug response are different. Some patients may develop drug resistance or other adverse effects, such as fatigue, high blood pressure, or eye discomfort. Therefore, doctors need to carefully evaluate the patient's overall condition to decide whether to recommend long-term use.

Regular monitoring and follow-up are critical for patients taking erdafitinib. This can help doctors understand the patient's condition changes and drug response in a timely manner, so as to make corresponding treatment adjustments.

To sum up, whether to take erdafitinib for a long time is not a simple question. It involves many considerations. The final decision should be made by doctors and patients based on their condition, drug response, and doctor’s advice. During the treatment process, patient cooperation and regular monitoring and follow-up are the keys to ensuring the effectiveness of the treatment.